Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
Go To English Page
Nomor Surat 068/CS-OPI/I/2025
Nama Perusahaan PT Organon Pharma Indonesia Tbk
Kode Emiten SCPI
Lampiran 1
Perihal Penyampaian Materi Public Expose Tahunan
Penyampaian Materi Public Expose
Merujuk pada rencana penyelenggaraan Public Expose Tahunan yang disampaikan Perseroan melalui
Surat No 065/CS-OPI/X/2025 Tanggal 06 Oktober 2025
Demikian untuk diketahui.
Hormat Kami,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Telepon : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Nama Pengirim Arie Noviandari
Jabatan approver dua
Tanggal dan Waktu 16-10-2025 15:35
Lampiran 1. OPI - Public Expose 2025_21Oct2025.pdf
Dokumen ini merupakan dokumen resmi PT Organon Pharma Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Organon Pharma Indonesia Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 2
Go To Indonesian Page
Letter / Announcement No. 068/CS-OPI/I/2025
Issuer Name PT Organon Pharma Indonesia Tbk
Issuer Code SCPI
Attachment 1
Subject Public Expose Material Submission
Public Expose Material Submission
Reffering to Company's public expose announcement Annual in Letter No. 065/CS-OPI/X/2025
date 06 October 2025 Company submitted public expose material as attached.
Thus to be informed accordingly.
Respectfully,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Phone : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Sender Name Arie Noviandari
Function approver dua
Date and Time 16-10-2025 15:35
Attachment 1. OPI - Public Expose 2025_21Oct2025.pdf
This is an official document of PT Organon Pharma Indonesia Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Organon Pharma Indonesia Tbk is fully responsible
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.